- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
TGF-β induced reprogramming and drug resistance in triple-negative breast cells ; volume:23 ; number:1 ; day:8 ; month:4 ; year:2022 ; pages:1-11 ; date:12.2022
BMC pharmacology & toxicology ; 23, Heft 1 (8.4.2022), 1-11, 12.2022
- Creator
-
Wu, Guoyu
Li, Yuchao
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40360-022-00561-x
- URN
-
urn:nbn:de:101:1-2022062523395773359223
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wu, Guoyu
- Li, Yuchao
- SpringerLink (Online service)
Other Objects (12)
Kindlin-2 regulates the oncogenic activities of integrins and TGF-β in triple-negative breast cancer progression and metastasis
The TGF-β signaling pathway in cholangiocarcinoma : = Der TGF-β Signaltransduktionsweg bei Cholangiokarzinomen
Signaltransduktion über TGF-β- [TGF-beta-] und BMP-Rezeptoren
TGF-β [TGF-beta] signaling at the cellular junctions
Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism
Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
TGF-β [TGF-Beta] und Empfindlichkeit für NO-abhängige Apoptose
TGF-β [TGF-Beta] und Empfindlichkeit für NO-abhängige Apoptose
Metastatic Triple-Negative Breast Cancer
HuR drives lung fibroblast differentiation but not metabolic reprogramming in response to TGF-β and hypoxia
Transcriptome reprogramming through alternative splicing triggered by apigenin drives cell death in triple-negative breast cancer
TGF-β signalling in nervous system development
Kindlin-2 regulates the oncogenic activities of integrins and TGF-β in triple-negative breast cancer progression and metastasis
The TGF-β signaling pathway in cholangiocarcinoma : = Der TGF-β Signaltransduktionsweg bei Cholangiokarzinomen
Signaltransduktion über TGF-β- [TGF-beta-] und BMP-Rezeptoren
TGF-β [TGF-beta] signaling at the cellular junctions
Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism
Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
TGF-β [TGF-Beta] und Empfindlichkeit für NO-abhängige Apoptose
TGF-β [TGF-Beta] und Empfindlichkeit für NO-abhängige Apoptose
Metastatic Triple-Negative Breast Cancer
HuR drives lung fibroblast differentiation but not metabolic reprogramming in response to TGF-β and hypoxia
Transcriptome reprogramming through alternative splicing triggered by apigenin drives cell death in triple-negative breast cancer
TGF-β signalling in nervous system development
Kindlin-2 regulates the oncogenic activities of integrins and TGF-β in triple-negative breast cancer progression and metastasis
The TGF-β signaling pathway in cholangiocarcinoma : = Der TGF-β Signaltransduktionsweg bei Cholangiokarzinomen
Signaltransduktion über TGF-β- [TGF-beta-] und BMP-Rezeptoren
TGF-β [TGF-beta] signaling at the cellular junctions
Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism
Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
TGF-β [TGF-Beta] und Empfindlichkeit für NO-abhängige Apoptose
TGF-β [TGF-Beta] und Empfindlichkeit für NO-abhängige Apoptose
Metastatic Triple-Negative Breast Cancer
HuR drives lung fibroblast differentiation but not metabolic reprogramming in response to TGF-β and hypoxia
Transcriptome reprogramming through alternative splicing triggered by apigenin drives cell death in triple-negative breast cancer